Coronavirus

Actions

Moderna says its COVID vaccine is 93% effective six months after second dose

Virus Outbreak Vaccine
Posted at 4:53 PM, Aug 05, 2021
and last updated 2021-08-05 16:53:59-04

Moderna said Thursday that its vaccine is 93% effective through six months after receiving the second dose.

In a news release, the company added that it tested three booster shots in phase 2 of its study, which demonstrated "robust antibody responses...against important variants of concern."

"We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat, so we must remain vigilant," said Stéphane Bancel, Chief Executive Officer of Moderna, in a press release.

Moderna added that they expect to complete its submission to the Food and Drug Administration for its vaccine to be fully distributed in August.

Moderna's announcement comes a week after Pfizer-BioNTech said its COVID-19 vaccine was 84% effective six months after complete vaccination, the New York Times reported.

According to the newspaper, the FDA aims to grant full approval Pfizer-BioNTech’s coronavirus vaccine by Labor Day or sooner.

Download our streaming app on your favorite device.  Click here for more.

Download our streaming app on your favorite device. Click here for more.